Glycomics Marke Size, Share, Expected Growth And Industry Analysis Report to 2032

Comments · 161 Views

The global glycomics market is anticipated to grow at a high CAGR of 13.9% from 2023 to 2032.

According to a new report published by K D Market Insights, titled, “Glycomics Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global glycomics market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The increasing focus on glycomics research, advancements in analytical technologies, and the rising importance of understanding glycan structures in various biological processes and disease mechanisms which are the major factors augmenting the growth of the global glycomics market. The global glycomics market is anticipated to grow at a high CAGR of 13.9% from 2023 to 2032. The market's revenue surged to $1.3 billion in 2022, and it is expected to further accelerate, reaching a notable $4.7 billion by 2032.

The increasing focus on glycomics research to understand glycan structures and their roles in various biological processes and disease mechanisms are further expected to create ample growth opportunities for the global glycomics market during the forecast period i.e., 2023-2032. Moreover, advancements in analytical technologies, particularly mass spectrometry and chromatography, have significantly enhanced the glycomics research process., has propelled market expansion. Rising prevalence of chronic diseases, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global glycomics market in 2022. The region is further projected to continue dominating in the market during the forecast period. This can be attributed to the well-established healthcare infrastructure, strong research and development activities, and the presence of key pharmaceutical and biotechnology companies.

According to product type, the enzymes segment accounted for the largest market share in the glycomics market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global glycomics market is segmented into product type, application, end user and region. Based on product type, the market is bifurcated into enzymes, instruments, kits, and reagents. Based on application, it is classified into diagnostics, drug discovery & development, oncology, immunology, others. Based on end user, it is classified into academic research institutes, pharmaceutical & biotechnology companies, contract research organizations.

The global glycomics market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Glycomics Market

  • On the basis of product type, the enzymes segment accounted for the largest market share in the glycomics market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
  • On the basis of region, North America accounted for the largest share in the global glycomics market in 2022. The region is further projected to continue dominating in the market during the forecast period.
  • On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.

Some of the major glycomics companies profiled in the report include Thermo Fisher Scientific, New England Biolabs, Merck KGaA, Promega Corporation, Waters Corporation, Takara Bio Inc, Bio-Techne, Agilent Technologies, Sumitomo Bakelite Co. Ltd., Bruker Corporation, Shimadzu Corporation, Danaher Corporation, AMS Bio, Ludger Ltd, Z Biotech, LLC, Chemily Glycoscience, CD BioGlyco, GlycoDiag, Kode Biotech Limited, Glyxera GmBH, Lectenz Bio, Glycomix Ltd, IEC Group, Asparia Glycomics, and Ray Biotech Life Inc.

Related Reports :-

https://www.kdmarketinsights.com/reports/preeclampsia-diagnostics-market/7142

https://www.kdmarketinsights.com/reports/postoperative-pain-management-market/7141

https://www.kdmarketinsights.com/reports/adhesion-barriers-market/7140

https://www.kdmarketinsights.com/reports/hereditary-angioedema-therapeutics-market/7139

Comments
ADVERTISE || APPLICATION || AFFILIATE



AS SEEN ON
AND OVER 250 NEWS SITES
Verified by SEOeStore